Xencor, Inc.
$14.98
The Read: Xencor’s stock historically rallies sharply when it delivers clinical data validating key pipeline candidates like XmAb808 and XmAb942 and provides reassuring cash runway guidance that eases financing concerns.
Price
Overlays
Panel
XNCR
Hover to view data
No Data